Working…
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02928224
Brief Title: Study of Encorafenib + Cetuximab Plus or Minus Binimetinib vs. Irinotecan/Cetuximab or Infusional 5-Fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab With a Safety Lead-in of Encorafenib + Binimetinib + Cetuximab in Patients With BRAF V600E-mutant Metastatic Colorectal Cancer (BEACON CRC)

First Submitted : August 16, 2016
First Submitted that Met QC Criteria : October 6, 2016
First Posted : October 10, 2016 (Estimate)

Certification/Extension First Submitted : December 19, 2019
Certification/Extension First Submitted that Met QC Criteria : December 19, 2019
Certification/Extension First Posted : December 20, 2019

Last Update Submitted that Met QC Criteria : December 19, 2019
Last Update Posted : December 20, 2019